Hydromorphone Hydrochloride 43602-0002
Product NDC
43602-0002- Manufacturer
- Ascent Pharmaceuticals Inc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- January 24, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA210506
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hydromorphone Hydrochloride | 2 mg/1 |
Drug Class
Full Opioid Agonists [MoA]Opioid Agonist [EPC]
Packaging Options(2)
500 TABLET in 1 BOTTLE (43602-002-05)
30 TABLET in 1 BOTTLE (43602-002-30)